» Articles » PMID: 34976659

Health-related Biological and Non-biological Consequences of Forgoing Healthcare for Economic Reasons

Overview
Journal Prev Med Rep
Date 2022 Jan 3
PMID 34976659
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Forgoing healthcare for economic reasons has been previously associated with adverse health outcomes, including a higher risk of hospitalization, a lower quality of life, and worse self-reported health. However, the exact cause-to-effect relation between forgoing healthcare and health-related outcomes has been insufficiently described. Here, we investigate the prospective health consequences of forgoing healthcare for economic reasons using data from "ReBus" (N = 400), a prospective study examining the health consequences of forgoing healthcare (Baseline: 2008-2013, Follow-up: 2014-2016). Using regression models, we explored the baseline determinants of forgoing healthcare, including socioeconomic, demographic, and pre-existing health-risk factors, and examined the associations between forgoing healthcare at baseline and health deterioration at follow-up, using highly pertinent biomarkers (glucose, glycated hemoglobin, lipids, blood pressure) and SF-36 questionnaire data. Low income, low occupation, low education, and smoking were associated with higher odds of forgoing healthcare at baseline. Forgoing healthcare for economic reasons at baseline was subsequently related to detrimental changes in glucose, high-density lipoprotein cholesterol (HDL), and blood pressure (BP) at follow-up, independently of baseline socioeconomic factors (Glucose-β = 0.19, 95%CI[0.03;0.34], HDL-β = -0.07, 95%CI[-0.14;0.01], BP-β = 3.30, 95%CI[-0.01;6.60]). Moreover, we found strong associations between forgoing healthcare and adverse SF-36 health scores at follow-up, with individuals forgoing healthcare systematically displaying worse health scores (6%-11% lower scores). For the first time, we show that forgoing healthcare for economic reasons predicts adverse health-related consequences 2-8 years later. Our findings shall further encourage the implementation of public health measures aimed at identifying individuals who forgo healthcare and preventing the adverse health consequences of unmet medical needs.

Citing Articles

The financial burden of noncommunicable diseases from out-of-pocket expenditure in sub-Saharan Africa: a scoping review.

Odunyemi A, Islam M, Alam K Health Promot Int. 2024; 39(5).

PMID: 39284918 PMC: 11405128. DOI: 10.1093/heapro/daae114.


Financial burden of seeking diabetes mellitus care in India: Evidence from a Nationally Representative Sample Survey.

Nanda M, Sharma R Health Care Sci. 2024; 2(5):291-305.

PMID: 38938589 PMC: 11168574. DOI: 10.1002/hcs2.65.


Trends and determinants of prevalence, awareness, treatment and control of dyslipidaemia in canton of Geneva, 2005-2019: Potent statins are underused.

Marques-Vidal P, Chekanova V, de Mestral C, Guessous I, Stringhini S Int J Cardiol Cardiovasc Risk Prev. 2023; 18:200187.

PMID: 37250185 PMC: 10209490. DOI: 10.1016/j.ijcrp.2023.200187.


Financial risk protection from out-of-pocket health spending in low- and middle-income countries: a scoping review of the literature.

Rahman T, Gasbarro D, Alam K Health Res Policy Syst. 2022; 20(1):83.

PMID: 35906591 PMC: 9336110. DOI: 10.1186/s12961-022-00886-3.

References
1.
Bodenmann P, Wolff H, Bischoff T, Herzig L, Warin P, Chatelard S . [Patients forgoing health care for economic reasons: how to identify this in a primary care setting?]. Rev Med Suisse. 2015; 10(452):2258, 2260-3. View

2.
Bodenmann P, Favrat B, Wolff H, Guessous I, Panese F, Herzig L . Screening primary-care patients forgoing health care for economic reasons. PLoS One. 2014; 9(4):e94006. PMC: 3974836. DOI: 10.1371/journal.pone.0094006. View

3.
Wolff H, Gaspoz J, Guessous I . Health care renunciation for economic reasons in Switzerland. Swiss Med Wkly. 2011; 141:w13165. DOI: 10.4414/smw.2011.13165. View

4.
Lins L, Carvalho F . SF-36 total score as a single measure of health-related quality of life: Scoping review. SAGE Open Med. 2016; 4:2050312116671725. PMC: 5052926. DOI: 10.1177/2050312116671725. View

5.
Chen J, Rizzo J, Rodriguez H . The health effects of cost-related treatment delays. Am J Med Qual. 2011; 26(4):261-71. DOI: 10.1177/1062860610390352. View